IBJHF yields 3.15% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, IBJHF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of IBJHF + PFE for your $10,000?
Ibstock plc manufactures and sells clay and concrete building products and solutions primarily in the United Kingdom. Its principal products include clay bricks, brick components, concrete roof tiles, concrete stone masonry substitutes, concrete fencing, pre-stressed concrete, and concrete rail products. The company provides facing bricks, special bricks, walling stones, architectural masonry products, facade systems, retaining walls, sills and arches, and padstones, as well as lintels, sills, and arches; cladding solutions; roof tiles, roof window systems, chimneys, soffits, and roofing accessories; and fencings, caps and copings, bollards, balustrades, path edgings, and urban landscaping products. It also offers floor beams, door steps, gully surrounds, screed rails, insulated floorings, and hollowcore products; and rail and infrastructure products, such as troughing, cable theft protection, boards, blocks, bases, catchpits, and inspection chambers. In addition, the company offers engraving, cutting, and bonding services; floor beam and block design, supply, and fitting solutions; bespoke concrete products; and staircases and lift shafts services. Its products are used in new build housing; repair, maintenance, and improvement; and infrastructure markets. The company sells its products under the Forticrete, Supreme, Anderton, and Longley brands to customers in the construction industry. Ibstock plc was founded in 1825 and is headquartered in Ibstock, the United Kingdom.
Full IBJHF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.